Recombinant Human PHLDA1 Protein，His

PHLDA1 (Pleckstrin Homology-Like Domains A1) is a protein that has gained significant interest in recent years due to its potential roles in various biological processes and its implications in disease. Initially identified as a protein involved in T-cell regulation, PHLDA1 has been linked to apoptosis, cell differentiation, and immune responses. Its role in cancer has become a focal point, as studies demonstrate that PHLDA1 expression is often downregulated in several malignancies, suggesting it may function as a tumor suppressor. Researchers have explored its capacity to inhibit cell growth and induce apoptosis in cancer cells, highlighting its potential as a therapeutic target. Additionally, PHLDA1 has been implicated in metabolic regulation and has shown interactions with several signaling pathways, which further emphasizes its biological significance. The recombination and production of PHLDA1 as a recombinant protein have enabled detailed structural and functional studies, providing insights into its mechanisms of action and interactions at the molecular level. Furthermore, understanding how PHLDA1 operates in both normal and pathological states could contribute to the development of novel diagnostic and therapeutic strategies in oncology and immunology. Therefore, the exploration of PHLDA1 as a recombinant protein not only aids in delineating its biological functions but also helps in assessing its potential utility in clinical applications. Overall, as research advances, the significance of PHLDA1 continues to unfold, revealing its multifaceted roles in health and disease, which warrants further investigation in the context of personalized medicine and targeted therapy.